Investigational Drug Information for Rolipram
✉ Email this page to a colleague
What is the development status for investigational drug Rolipram?
Rolipram is an investigational drug.
There have been 9 clinical trials for Rolipram.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2001.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Depressive Disorder, Major. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), Sadat City University, and National Institute of Neurological Disorders and Stroke (NINDS).
Summary for Rolipram
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 5,015 |
| WIPO Patent Applications | 482 |
| Japanese Patent Applications | 1,660 |
| Clinical Trial Progress | Phase 2 (2001-02-01) |
| Vendors | 108 |
Recent Clinical Trials for Rolipram
| Title | Sponsor | Phase |
|---|---|---|
| [11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine | National Institute of Mental Health (NIMH) | Early Phase 1 |
| The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients | Sadat City University | Phase 1/Phase 2 |
| PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome | National Institute of Mental Health (NIMH) | Phase 1/Phase 2 |
Clinical Trial Summary for Rolipram
Top disease conditions for Rolipram
Top clinical trial sponsors for Rolipram
US Patents for Rolipram
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
